About Horizon pharma
Horizon Pharma: Transforming Lives with Science and Compassion
Horizon Pharma is a global biotechnology company that is dedicated to improving the lives of patients suffering from rare and rheumatic diseases. The company was founded in 2005 with a mission to develop innovative therapies that address unmet medical needs. Today, Horizon Pharma has become a leading player in the biotech industry, with a portfolio of products that are making a real difference in the lives of patients around the world.
At Horizon Pharma, we believe that science and compassion must work together to transform lives. We are committed to developing therapies that not only treat diseases but also improve patients' quality of life. Our team of scientists, researchers, and healthcare professionals works tirelessly to discover new treatments for rare diseases such as gout, lupus nephritis, and thyroid eye disease.
One of our flagship products is KRYSTEXXA®, an FDA-approved therapy for chronic refractory gout (CRG). CRG is a debilitating condition that affects millions of people worldwide. KRYSTEXXA® has been shown to significantly reduce uric acid levels in patients with CRG, providing relief from pain and inflammation.
Another product in our portfolio is TEPEZZA®, an FDA-approved therapy for thyroid eye disease (TED). TED is a rare autoimmune disorder that causes inflammation around the eyes, leading to vision loss and disfigurement. TEPEZZA® has been shown to reduce inflammation and improve vision in patients with TED.
In addition to developing innovative therapies, Horizon Pharma also provides support services for patients who are living with rare diseases. We understand how challenging it can be for patients who are dealing with complex medical conditions. That's why we offer resources such as patient education materials, financial assistance programs, and access support services.
At Horizon Pharma, we are committed to making a positive impact on society through our work in biotechnology. We believe that by combining scientific innovation with compassion for others, we can transform lives one patient at a time.
Our commitment extends beyond just developing new therapies; it also includes being responsible corporate citizens who prioritize sustainability practices across all aspects of our business operations – from research & development through manufacturing & distribution – so as not only benefitting those who use our products but also protecting future generations by reducing environmental impacts wherever possible while maintaining high standards throughout every step along this journey towards better health outcomes globally!
In conclusion,
Horizon pharma stands out among other biotech companies due its unwavering commitment towards transforming lives through science-driven innovation coupled up by compassionate care delivery models aimed at improving quality-of-life outcomes among its diverse patient populations worldwide!